160 related articles for article (PubMed ID: 31772683)
1. Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.
Li Y; Jiao Y; Li Y; Liu Y
Dis Markers; 2019; 2019():1569049. PubMed ID: 31772683
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
Xing J; Tian Y; Ji W; Wang X
Medicine (Baltimore); 2020 Feb; 99(9):e19230. PubMed ID: 32118724
[TBL] [Abstract][Full Text] [Related]
3.
Jiao Y; Li Y; Fu Z; Hou L; Chen Q; Cai Y; Jiang P; He M; Yang Z
Dis Markers; 2019; 2019():9037131. PubMed ID: 31781311
[TBL] [Abstract][Full Text] [Related]
4. HN1 as a diagnostic and prognostic biomarker for liver cancer.
Liu Z; Yang D; Li Y; Jiao Y; Lv G
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32700728
[TBL] [Abstract][Full Text] [Related]
5. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
Jiao Y; Li Y; Ji B; Cai H; Liu Y
J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer.
Jiao Y; Li Y; Jia B; Chen Q; Pan G; Hua F; Liu Y
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31967298
[TBL] [Abstract][Full Text] [Related]
8. GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival.
Yang D; Ji F; Li Y; Jiao Y; Fang X
Technol Cancer Res Treat; 2020; 19():1533033820945817. PubMed ID: 32812493
[TBL] [Abstract][Full Text] [Related]
9. High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.
Li Y; Jiao Y; Luo Z; Li Y; Liu Y
Medicine (Baltimore); 2019 Nov; 98(44):e17703. PubMed ID: 31689799
[TBL] [Abstract][Full Text] [Related]
10. Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma.
Koso H; Yi H; Sheridan P; Miyano S; Ino Y; Todo T; Watanabe S
Cancer Res; 2016 Apr; 76(8):2254-64. PubMed ID: 26933087
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
13. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
[TBL] [Abstract][Full Text] [Related]
14. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
Chen H; Li Y; Xiao SY; Guo J
BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
16. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
18. A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.
Liu X; Niu X; Qiu Z
DNA Cell Biol; 2020 Sep; 39(9):1621-1638. PubMed ID: 32758021
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Li J; Chen N; Gong X
Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]